UHRF1 Protein
Overview
UHRF1 (Ubiquitin-like with PHD and RING Finger Domains 1), also known as ICBP90 or TNP1, is a multifunctional regulatory protein composed of 110 kDa that plays critical roles in epigenetic regulation, DNA damage response, and cell cycle control. The protein belongs to the SRA (SET and RING-associated) protein family and serves as a key interface between DNA methylation machinery and chromatin remodeling complexes. UHRF1 is encoded by the UHRF1 gene located on chromosome 19p13.3 and is ubiquitously expressed across tissue types, with particularly high levels in metabolically active tissues including the brain. Its dual functionality as both a reader of epigenetic marks and an E3 ubiquitin ligase positions UHRF1 as a critical node in maintaining cellular homeostasis and genomic stability—processes fundamentally disrupted in neurodegenerative disease.
Function and Biology
UHRF1 possesses a sophisticated multi-domain architecture enabling its diverse cellular functions. The protein contains an N-terminal ubiquitin-like (UBL) domain, a central plant homeodomain (PHD) that specifically recognizes histone H3 methylation marks (particularly H3K9me3), an SRA domain that binds hemimethylated CpG DNA, and a C-terminal RING finger domain with E3 ubiquitin ligase activity. This structural arrangement enables UHRF1 to simultaneously recognize both histone and DNA methylation signals, functioning as a critical epigenetic reader.
...UHRF1 Protein
Overview
UHRF1 (Ubiquitin-like with PHD and RING Finger Domains 1), also known as ICBP90 or TNP1, is a multifunctional regulatory protein composed of 110 kDa that plays critical roles in epigenetic regulation, DNA damage response, and cell cycle control. The protein belongs to the SRA (SET and RING-associated) protein family and serves as a key interface between DNA methylation machinery and chromatin remodeling complexes. UHRF1 is encoded by the UHRF1 gene located on chromosome 19p13.3 and is ubiquitously expressed across tissue types, with particularly high levels in metabolically active tissues including the brain. Its dual functionality as both a reader of epigenetic marks and an E3 ubiquitin ligase positions UHRF1 as a critical node in maintaining cellular homeostasis and genomic stability—processes fundamentally disrupted in neurodegenerative disease.
Function and Biology
UHRF1 possesses a sophisticated multi-domain architecture enabling its diverse cellular functions. The protein contains an N-terminal ubiquitin-like (UBL) domain, a central plant homeodomain (PHD) that specifically recognizes histone H3 methylation marks (particularly H3K9me3), an SRA domain that binds hemimethylated CpG DNA, and a C-terminal RING finger domain with E3 ubiquitin ligase activity. This structural arrangement enables UHRF1 to simultaneously recognize both histone and DNA methylation signals, functioning as a critical epigenetic reader.
In normal cellular physiology, UHRF1 functions as a critical regulator of DNA methylation maintenance through its association with DNMT1 (DNA methyltransferase 1). The protein recognizes hemimethylated CpG dinucleotides during DNA replication and recruits DNMT1 to these sites, ensuring faithful propagation of methylation patterns through cell division. Additionally, UHRF1 acts as an E3 ubiquitin ligase targeting multiple substrates, including histone proteins and cell cycle regulators, thereby influencing chromatin structure and transcriptional regulation. Its PHD domain binding to methylated histones links DNA methylation to histone modifications, creating an integrated epigenetic regulatory system.
Role in Neurodegeneration
UHRF1 dysfunction has emerged as a significant contributor to neurodegeneration through multiple mechanistic pathways. Loss of UHRF1 function leads to aberrant DNA methylation patterns and disrupted chromatin organization, compromising transcriptional fidelity essential for neuronal homeostasis. In Alzheimer's disease, dysregulation of UHRF1-mediated epigenetic control contributes to altered expression of genes involved in amyloid-beta processing and tau phosphorylation. Studies demonstrate that UHRF1 levels decline with aging and in neurodegenerative disease states, correlating with increased genomic instability and accumulated DNA damage in neurons.
UHRF1 also regulates the expression of genes critical for neuronal protection and DNA repair, including BRCA1 and other homologous recombination factors. Compromised UHRF1 activity reduces the capacity of neurons to respond to DNA damage and oxidative stress—hallmarks of Alzheimer's disease, Parkinson's disease, and other tauopathies. Furthermore, UHRF1 mutations or reduced expression impair the ubiquitin-proteasome system's function, leading to accumulation of misfolded proteins characteristic of neurodegenerative pathology.
Molecular Mechanisms
UHRF1 operates through several integrated molecular mechanisms in neurodegeneration. The protein's E3 ubiquitin ligase activity targets substrates for proteasomal degradation, including p53, CDC20, and CHK1, thereby regulating checkpoint control and apoptosis. Phosphorylation of UHRF1 by ATM and DNA-PKcs in response to DNA damage modulates its localization and activity, integrating it into the DNA damage response pathway. UHRF1-mediated histone ubiquitination influences chromatin accessibility at genes encoding neuroprotective factors, directly impacting cellular stress responses.
Age-related decline in UHRF1 expression reduces its capacity to maintain epigenetic stability, contributing to the accumulation of aberrant gene expression patterns observed in aged neurons and neurodegenerative disease.
Clinical and Research Significance
UHRF1 represents a promising therapeutic target for neurodegenerative diseases. Restoring UHRF1 expression or activity could enhance DNA repair capacity, maintain epigenetic integrity, and reduce neuronal vulnerability to proteotoxic stress. Recent research indicates that modulating UHRF1 function may ameliorate cognitive decline in Alzheimer's disease models by preserving gene expression programs essential for neuronal survival and synaptic plasticity.
- DNMT1 (DNA Methyltransferase 1)
- BRCA1 (Breast Cancer Type 1 Susceptibility Protein)
- H3K9me3 (Histone H3 Lysine 9 Trimethylation)
- Epigenetic Regulation in Neurodegeneration